找回密码
 To register

QQ登录

只需一步,快速开始

扫一扫,访问微社区

新窗
投票 ESCI期刊Australian Prescriber 2024/2025影响因子:3.474 (AUST PRESCR) (0312-8008). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging So  ...234
Total Citations:1046; 2023 JIF:3.474; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:3.587; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:0.6; Immediacy Index-dealt:0.685; 2023 JCI:0.8; JCI Rank: 125/354 ; Total Articles:8; JCI Quartile:Q2; JCI Percentile:64.83; Eigenfactor:0.001; Normalized Eigenfactor:0.227; Article Influence Score:0.995; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q1; Citable Items:9; % of Articles in Citable items:0.8889; Cited Half-Life:6.5; Citing Half-Life:3.9; % of OA Gold:1; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Journal of Anaesthesiology Clinical Pharmacology 2024/2025影响因子:1.548 (J ANAESTH CLIN PHARM) (0970-9185). (PHARMAC  ...234
Total Citations:1916; 2023 JIF:1.548; JIFRank: 265/354 ; Rank-JIF: 265; Number-of-JIF:354; 5 Year JIF:1.826; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.5; Immediacy Index:0.3; Immediacy Index-dealt:0.375; 2023 JCI:0.26; JCI Rank: 302/354 ; Total Articles:77; JCI Quartile:Q4; JCI Percentile:14.83; Eigenfactor:0.002; Normalized Eigenfactor:0.328; Article Influence Score:0.41; JIF Percentile:25.3; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:81; % of Articles in Citable items:0.9506; Cited Half-Life:6.5; Citing Half-Life:10; % of OA Gold:0.973; Publisher name:WILEY; Publisher address:111 RIVER ST, HOBOKEN, USA, NJ, 07030-5774;
投票 ESCI期刊Drug Research 2024/2025影响因子:1.753 (DRUG RES) (2194-9379). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sources Citat  ...234
Total Citations:1447; 2023 JIF:1.753; JIFRank: 251/354 ; Rank-JIF: 251; Number-of-JIF:354; 5 Year JIF:1.848; 5 Year JIF Quartile:Q3; JIF Without Self Cites:1.6; Immediacy Index:0.6; Immediacy Index-dealt:0.677; 2023 JCI:0.36; JCI Rank: 278/354 ; Total Articles:30; JCI Quartile:Q4; JCI Percentile:21.61; Eigenfactor:0.001; Normalized Eigenfactor:0.201; Article Influence Score:0.283; JIF Percentile:29.2; JIF Quartile:Q3; AIS Quartile:Q4; Citable Items:46; % of Articles in Citable items:0.6522; Cited Half-Life:5.9; Citing Half-Life:8.5; % of OA Gold:0.0375; Publisher name:OXFORD UNIV PRESS; Publisher address:GREAT CLARENDON ST, OXFORD, ENGLAND, O
投票 ESCI期刊PharmaNutrition 2024/2025影响因子:2.441 (PHARMANUTRITION) (2213-4344). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sour  ...234
Total Citations:642; 2023 JIF:2.441; JIFRank: 188/354 ; Rank-JIF: 188; Number-of-JIF:354; 5 Year JIF:2.329; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.2; Immediacy Index:0.6; Immediacy Index-dealt:0.674; 2023 JCI:0.62; JCI Rank: 192/354 ; Total Articles:25; JCI Quartile:Q3; JCI Percentile:45.9; Eigenfactor:0; Normalized Eigenfactor:0.107; Article Influence Score:0.366; JIF Percentile:47; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:34; % of Articles in Citable items:0.7353; Cited Half-Life:4.4; Citing Half-Life:7.5; % of OA Gold:0.2184; Publisher name:INDIAN ACAD SCIENCES; Publisher address:C V RAMAN AVENUE, SADASHIVANAGAR, P B #8005
投票 ESCI期刊Current Drug Therapy 2024/2025影响因子:0.377 (CURR DRUG THER) (1574-8855). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging  ...234
Total Citations:224; 2023 JIF:0.377; JIFRank: 344/354 ; Rank-JIF: 344; Number-of-JIF:354; 5 Year JIF:0.649; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.3; Immediacy Index:0.1; Immediacy Index-dealt:0.111; 2023 JCI:0.13; JCI Rank: 332/354 ; Total Articles:29; JCI Quartile:Q4; JCI Percentile:6.36; Eigenfactor:0; Normalized Eigenfactor:0.02; Article Influence Score:0.07; JIF Percentile:3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:59; % of Articles in Citable items:0.4915; Cited Half-Life:7.1; Citing Half-Life:8.6; % of OA Gold:0.015; Publisher name:CELL PRESS; Publisher address:50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 02139;
投票 ESCI期刊Clinical Pharmacology-Advances and Applications 2024/2025影响因子:3.192 (CLIN PHARMACOL-ADV A) (1179-1438). (PHARMACO  ...234
Total Citations:529; 2023 JIF:3.192; JIFRank: 126/354 ; Rank-JIF: 126; Number-of-JIF:354; 5 Year JIF:2.601; 5 Year JIF Quartile:Q3; JIF Without Self Cites:3.1; Immediacy Index:0.3; Immediacy Index-dealt:0.308; 2023 JCI:0.51; JCI Rank: 232/354 ; Total Articles:7; JCI Quartile:Q3; JCI Percentile:34.6; Eigenfactor:0; Normalized Eigenfactor:0.107; Article Influence Score:0.665; JIF Percentile:64.5; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:11; % of Articles in Citable items:0.6364; Cited Half-Life:6.7; Citing Half-Life:7.9; % of OA Gold:1; Publisher name:SPRINGER HEIDELBERG; Publisher address:TIERGARTENSTRASSE 17, HEIDELBERG, GERMANY, D-691
投票 ESCI期刊Neuropsychopharmacology Reports 2024/2025影响因子:2.138 (NEUROPSYCHOPHARM REP) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与  ...234
Total Citations:608; 2023 JIF:2.138; JIFRank: 222/354 ; Rank-JIF: 222; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:1.9; Immediacy Index:0.2; Immediacy Index-dealt:0.244; 2023 JCI:0.53; JCI Rank: 225/354 ; Total Articles:86; JCI Quartile:Q3; JCI Percentile:36.58; Eigenfactor:0.001; Normalized Eigenfactor:0.805; Article Influence Score:1.021; JIF Percentile:37.4; JIF Quartile:Q3; AIS Quartile:NULL; Citable Items:94; % of Articles in Citable items:0.9149; Cited Half-Life:3; Citing Half-Life:9.6; % of OA Gold:0.7437; Publisher name:GALENOS PUBL HOUSE; Publisher address:Kacamak Sokak 21/1, ISTANBUL, Turkiye
投票 ESCI期刊SCIENTIA PHARMACEUTICA 2024/2025影响因子:2.363 (SCI PHARM) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sources  ...234
Total Citations:1840; 2023 JIF:2.363; JIFRank: 199/354 ; Rank-JIF: 199; Number-of-JIF:354; 5 Year JIF:2.921; 5 Year JIF Quartile:Q2; JIF Without Self Cites:2.2; Immediacy Index:0.9; Immediacy Index-dealt:0.924; 2023 JCI:0.67; JCI Rank: 171/354 ; Total Articles:41; JCI Quartile:Q2; JCI Percentile:51.84; Eigenfactor:0.001; Normalized Eigenfactor:0.19; Article Influence Score:0.397; JIF Percentile:43.9; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:55; % of Articles in Citable items:0.7455; Cited Half-Life:6.9; Citing Half-Life:7.7; % of OA Gold:1; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON, E
投票 ESCI期刊JOURNAL OF PHARMACY PRACTICE 2024/2025影响因子:1.113 (J PHARM PRACT) (0897-1900). (PHARMACOLOGY & PHARMACY)(药理学与药学)Em  ...234
Total Citations:1684; 2023 JIF:1.113; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:1.266; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.2; Immediacy Index-dealt:0.263; 2023 JCI:0.29; JCI Rank: 293/354 ; Total Articles:64; JCI Quartile:Q4; JCI Percentile:17.37; Eigenfactor:0.002; Normalized Eigenfactor:0.501; Article Influence Score:0.313; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:75; % of Articles in Citable items:0.8533; Cited Half-Life:4.1; Citing Half-Life:6.9; % of OA Gold:0.0444; Publisher name:WORLD SCIENTIFIC PUBL CO PTE LTD; Publisher address:5 TOH TUCK LINK, SINGAPOR
投票 ESCI期刊JAC-Antimicrobial Resistance 2024/2025影响因子:3.768 (JAC-ANTIMICROB RESIS) (NULL). (PHARMACOLOGY & PHARMACY)(药理学与药学)  ...234
Total Citations:1419; 2023 JIF:3.768; JIFRank: 90/354 ; Rank-JIF: 90; Number-of-JIF:354; 5 Year JIF:3.962; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.5; Immediacy Index:0.4; Immediacy Index-dealt:0.451; 2023 JCI:0.73; JCI Rank: 154/354 ; Total Articles:135; JCI Quartile:Q2; JCI Percentile:57.45; Eigenfactor:0.003; Normalized Eigenfactor:0.705; Article Influence Score:1.114; JIF Percentile:62.4; JIF Quartile:Q2; AIS Quartile:Q2; Citable Items:150; % of Articles in Citable items:0.9; Cited Half-Life:2.4; Citing Half-Life:5.2; % of OA Gold:0.9277; Publisher name:PENN STATE UNIV PRESS; Publisher address:820 NORTH UNIV DRIVE, U S B 1, STE C,
投票 ESCI期刊HOSPITAL PHARMACY 2024/2025影响因子:0.896 (HOSP PHARM) (0018-5787). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sources  ...234
Total Citations:918; 2023 JIF:0.896; JIFRank: 311/354 ; Rank-JIF: 311; Number-of-JIF:354; 5 Year JIF:0.986; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.8; Immediacy Index:0.1; Immediacy Index-dealt:0.109; 2023 JCI:0.17; JCI Rank: 324/354 ; Total Articles:69; JCI Quartile:Q4; JCI Percentile:8.62; Eigenfactor:0.001; Normalized Eigenfactor:0.177; Article Influence Score:0.242; JIF Percentile:12.3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:86; % of Articles in Citable items:0.8023; Cited Half-Life:6.7; Citing Half-Life:4.7; % of OA Gold:0.0463; Publisher name:INST MATHEMATICAL STATISTICS-IMS; Publisher address:3163 SOMERSET DR, CLEVELA
投票 ESCI期刊ADMET and DMPK 2024/2025影响因子:3.479 (ADMET DMPK) (1848-7718). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sources Ci  ...234
Total Citations:421; 2023 JIF:3.479; JIFRank: 105/354 ; Rank-JIF: 105; Number-of-JIF:354; 5 Year JIF:2.825; 5 Year JIF Quartile:Q2; JIF Without Self Cites:3.3; Immediacy Index:0.8; Immediacy Index-dealt:0.852; 2023 JCI:0.73; JCI Rank: 154/354 ; Total Articles:30; JCI Quartile:Q2; JCI Percentile:56.64; Eigenfactor:0; Normalized Eigenfactor:0.085; Article Influence Score:0.449; JIF Percentile:70.5; JIF Quartile:Q2; AIS Quartile:Q3; Citable Items:44; % of Articles in Citable items:0.6818; Cited Half-Life:3.5; Citing Half-Life:5.7; % of OA Gold:0.9762; Publisher name:TAYLOR & FRANCIS LTD; Publisher address:2-4 PARK SQUARE, MILTON PARK, ABINGDON,
投票 ESCI期刊JOURNAL OF PHARMACY PRACTICE AND RESEARCH 2024/2025影响因子:1.179 (J PHARM PRACT RES) (1445-937X). (PHARMACOLOGY & PH  ...234
Total Citations:546; 2023 JIF:1.179; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:NULL; 5 Year JIF Quartile:NULL; JIF Without Self Cites:0.9; Immediacy Index:0.1; Immediacy Index-dealt:0.163; 2023 JCI:0.22; JCI Rank: 309/354 ; Total Articles:33; JCI Quartile:Q4; JCI Percentile:12.85; Eigenfactor:0.001; Normalized Eigenfactor:0.501; Article Influence Score:0.313; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:NULL; Citable Items:41; % of Articles in Citable items:0.8049; Cited Half-Life:5.7; Citing Half-Life:6; % of OA Gold:0.2721; Publisher name:INDERSCIENCE ENTERPRISES LTD; Publisher address:WORLD TRADE CENTER BLDG, 29
投票 ESCI期刊Annales Pharmaceutiques Francaises 2024/2025影响因子:1.165 (ANN PHARM FR) (0003-4509). (PHARMACOLOGY & PHARMACY)(药理学与  ...234
Total Citations:615; 2023 JIF:1.165; JIFRank: 301/354 ; Rank-JIF: 301; Number-of-JIF:354; 5 Year JIF:1.135; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.9; Immediacy Index:0.3; Immediacy Index-dealt:0.363; 2023 JCI:0.27; JCI Rank: 301/354 ; Total Articles:83; JCI Quartile:Q4; JCI Percentile:15.11; Eigenfactor:0; Normalized Eigenfactor:0.082; Article Influence Score:0.17; JIF Percentile:15.1; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:97; % of Articles in Citable items:0.8557; Cited Half-Life:6.3; Citing Half-Life:8; % of OA Gold:0.2795; Publisher name:PNG PUBLICATIONS; Publisher address:2205-K OAK RIDGE RD, #115, OAK RIDGE, USA, NC,
投票 ESCI期刊Advances in Pharmacological and Pharmaceutical Sciences 2024/2025影响因子:2.132 (ADV PHARM PHARM SCI) (2633-4682). (P  ...234
Total Citations:331; 2023 JIF:2.132; JIFRank: 210/354 ; Rank-JIF: 210; Number-of-JIF:354; 5 Year JIF:2.661; 5 Year JIF Quartile:Q3; JIF Without Self Cites:2.1; Immediacy Index:0.7; Immediacy Index-dealt:0.787; 2023 JCI:0.62; JCI Rank: 192/354 ; Total Articles:32; JCI Quartile:Q3; JCI Percentile:45.9; Eigenfactor:0; Normalized Eigenfactor:0.078; Article Influence Score:0.372; JIF Percentile:40.8; JIF Quartile:Q3; AIS Quartile:Q3; Citable Items:40; % of Articles in Citable items:0.8; Cited Half-Life:2.4; Citing Half-Life:7.4; % of OA Gold:1; Publisher name:NULL; Publisher address:NULL;
投票 ESCI期刊Journal of Pharmacology & Pharmacotherapeutics 2024/2025影响因子:0.487 (J PHARMACOL PHARMACO) (0976-500X). (PHARMACOL  ...234
Total Citations:1294; 2023 JIF:0.487; JIFRank: 335/354 ; Rank-JIF: 335; Number-of-JIF:354; 5 Year JIF:0.418; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.4; Immediacy Index:0.3; Immediacy Index-dealt:0.302; 2023 JCI:0.07; JCI Rank: 347/354 ; Total Articles:18; JCI Quartile:Q4; JCI Percentile:2.12; Eigenfactor:0; Normalized Eigenfactor:0.025; Article Influence Score:0.089; JIF Percentile:5.5; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:24; % of Articles in Citable items:0.75; Cited Half-Life:10.7; Citing Half-Life:8.7; % of OA Gold:0.6132; Publisher name:SPRINGER; Publisher address:ONE NEW YORK PLAZA, SUITE 4600 , NEW YORK, United Stat
投票 ESCI期刊Current Drug Safety 2024/2025影响因子:1.151 (CURR DRUG SAF) (1574-8863). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging So  ...234
Total Citations:755; 2023 JIF:1.151; JIFRank: 296/354 ; Rank-JIF: 296; Number-of-JIF:354; 5 Year JIF:1.511; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1.1; Immediacy Index:0.4; Immediacy Index-dealt:0.445; 2023 JCI:0.31; JCI Rank: 292/354 ; Total Articles:70; JCI Quartile:Q4; JCI Percentile:17.66; Eigenfactor:0.001; Normalized Eigenfactor:0.13; Article Influence Score:0.363; JIF Percentile:16.5; JIF Quartile:Q4; AIS Quartile:Q3; Citable Items:88; % of Articles in Citable items:0.7955; Cited Half-Life:7.9; Citing Half-Life:9.6; % of OA Gold:0.0282; Publisher name:CELL PRESS; Publisher address:50 HAMPSHIRE ST, FLOOR 5, CAMBRIDGE, USA, MA, 0
投票 ESCI期刊US PHARMACIST 2024/2025影响因子:0.384 (US PHARM) (0148-4818). (PHARMACOLOGY & PHARMACY)(药理学与药学)Emerging Sources Citat  ...234
Total Citations:332; 2023 JIF:0.384; JIFRank: 344/354 ; Rank-JIF: 344; Number-of-JIF:354; 5 Year JIF:0.481; 5 Year JIF Quartile:Q4; JIF Without Self Cites:0.2; Immediacy Index:0.1; Immediacy Index-dealt:0.133; 2023 JCI:0.05; JCI Rank: 349/354 ; Total Articles:90; JCI Quartile:Q4; JCI Percentile:1.55; Eigenfactor:0; Normalized Eigenfactor:0.055; Article Influence Score:0.077; JIF Percentile:3; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:91; % of Articles in Citable items:0.989; Cited Half-Life:6.5; Citing Half-Life:6.4; % of OA Gold:0; Publisher name:WEST AFRICAN ORNITHOLOGICAL SOC; Publisher address:C/O DR ALAN TYE, EDITOR, 2 SCHOOL LANE,
投票 ESCI期刊Biuletyn Wydzialu Farmaceutycznego Warszawskiego Uniwersytetu Medycznego 2024/2025影响因子:0.126 (BIUL WYDZ FARM WARSZ  ...234
Total Citations:43; 2023 JIF:0.126; JIFRank: 352/354 ; Rank-JIF: 352; Number-of-JIF:354; 5 Year JIF:0.109; 5 Year JIF Quartile:Q4; JIF Without Self Cites:<0.1; Immediacy Index:1.3; Immediacy Index-dealt:1.399; 2023 JCI:0.02; JCI Rank: 353/354 ; Total Articles:6; JCI Quartile:Q4; JCI Percentile:0.42; Eigenfactor:0; Normalized Eigenfactor:0; Article Influence Score:0.004; JIF Percentile:0.7; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:27; % of Articles in Citable items:0.2222; Cited Half-Life:NULL; Citing Half-Life:6.9; % of OA Gold:0.6341; Publisher name:WOLTERS KLUWER MEDKNOW PUBLICATIONS; Publisher address:WOLTERS KLUWER INDIA PVT LTD ,
投票 ESCI期刊Journal of Pharmacy & Pharmacognosy Research 2024/2025影响因子:1.249 (J PHARM PHARMACOGN R) (0719-4250). (PHARMACOLOG  ...234
Total Citations:411; 2023 JIF:1.249; JIFRank: 290/354 ; Rank-JIF: 290; Number-of-JIF:354; 5 Year JIF:1.176; 5 Year JIF Quartile:Q4; JIF Without Self Cites:1; Immediacy Index:0.3; Immediacy Index-dealt:0.346; 2023 JCI:0.41; JCI Rank: 267/354 ; Total Articles:86; JCI Quartile:Q4; JCI Percentile:24.72; Eigenfactor:0; Normalized Eigenfactor:0.07; Article Influence Score:0.128; JIF Percentile:18.2; JIF Quartile:Q4; AIS Quartile:Q4; Citable Items:91; % of Articles in Citable items:0.9451; Cited Half-Life:2.8; Citing Half-Life:6; % of OA Gold:0.4825; Publisher name:IVYSPRING INT PUBL; Publisher address:PO BOX 4546, LAKE HAVEN, AUSTRALIA, NSW, 2263;
下一页 »
 关于派博传思  派博传思旗下网站  友情链接
派博传思介绍 公司地理位置 论文服务流程 影响因子官网 SITEMAP 大讲堂 北京大学 Oxford Uni. Harvard Uni.
发展历史沿革 期刊点评 投稿经验总结 SCIENCEGARD IMPACTFACTOR 派博系数 清华大学 Yale Uni. Stanford Uni.
|Archiver|手机版|小黑屋| 派博传思国际 ( 京公网安备110108008328) GMT+8, 2025-7-8 01:00
Copyright © 2001-2015 派博传思   京公网安备110108008328 版权所有 All rights reserved
返回顶部 返回版块